Heterogeneity in preferences for smoking cessation

Health Economics
Robert W PatersonPaul De Civita

Abstract

Promoting cessation is a cornerstone of tobacco control efforts by public-health agencies. Economic information to support cessation programs has generally emphasized cost-effectiveness or the impact of cigarette pricing and smoking restrictions on quit rates. In contrast, this study provides empirical estimates of smoker preferences for increased efficacy and other attributes of smoking cessation therapies (SCTs). Choice data were collected through a national survey of Canadian smokers. We find systematic preference heterogeneity for therapy types and SCT attributes between light and heavy smokers, as well as random heterogeneity using random parameters logit models. Preference heterogeneity is greatest between length of use and types of SCTs. We estimate that light smokers would be willing to pay nearly $500 ($CAN) to increase success rates to 40% with the comparable figure for heavy smokers being near $300 ($CAN). Results from this study can be used to inform research and development for smoking cessation products and programs and suggest important areas of future inquiry regarding heterogeneity of smoker preferences and preferences for other health programs.

References

Jan 1, 1995·Health Economics·T W HuJ Bartlett
Mar 8, 1998·Journal of Health Services Research & Policy·M van der Pol, J Cairns
Jul 12, 2002·Health Economics·Theodore E KeelerHai-Yen Sung
May 15, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·John A Tauras, Frank J Chaloupka
Sep 17, 2004·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Susan BuschJody Sindelar
Sep 24, 2004·Health Economics·Henrik Hammar, Fredrik Carlsson
Jun 21, 2006·Health Economics·Trine KjaerKristian Hart-Hansen

❮ Previous
Next ❯

Citations

Jun 28, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Joachim Marti
Jan 22, 2014·PharmacoEconomics·Aleksandra TorbicaFabio Ayala
Dec 2, 2015·Health Economics·Erik Nesson
Apr 23, 2016·American Journal of Preventive Medicine·David M CutlerMartha A Starr
Jul 29, 2011·Health Economics·Shelby Gerking, Raman Khaddaria
Jul 15, 2020·American Journal of Respiratory and Critical Care Medicine·Frank T LeoneHarold J Farber
Nov 26, 2015·Journal of Public Health Management and Practice : JPHMP·Shanta R DubeXin Xu
Feb 22, 2018·PharmacoEconomics Open·Kabindra RegmiNik Annie Afiqah Tuha
Oct 21, 2019·Patient Education and Counseling·David A KatzGary Gaeth
Jul 27, 2021·Journal of Smoking Cessation·Marianne Lund, Elisabeth Kvaavik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.